MOSCOW (MRC) -- Arkema has appointed Velox GmbH, Hamburg, Germany, as its exclusive distributor for the medical business development in Europe, according to GV.
In the North America region, Arkema continues its collaboration with Foster Corporation.
The product range includes Pebax SA 01 Med, Rilsan Med, Rilsamid Med, and Rilsan Clear Med. Pebax SA 01 Med polyether block amides find application in the production of medical tubing and angioplasty balloons. Arkema says that they have become a standard in cardiovascular devices, including percutaneous transluminal coronary angioplasty (PTCA) catheters.
We remind that, as MRC wrote previously, last year Arkema announced its 2016 ambition to become a world leader in specialty chemicals and advanced materials. With a selective and profitable growth strategy, the group targets sales of EUR8 billion and an EBITDA margin of 16% in 2016 while maintaining gearing below 40%. The group also intends to maintain its pace of development and aims to achieve sales of EUR10 billion with an EBITDA margin close to 17% in 2020.
Arkema is a leading European supplier of chlorochemicals and PVC. A subsidiary of the Arkema Group, Coatex specializes in the manufacture and marketing of flow additives used in a large number of markets. With a global presence, industrial sites in France, the Netherlands, the United States, China and Korea, and sales offices on five continents, Coatex reported sales of around EUR180 million in 2011.
MRC